This is of particular interest given the involvement of ERK1/2 in proliferation, survival, and cell migration in multiple other neoplasias [23,30,31] and the pro-migratory and pro-metastatic effects of N-cadherin in cancer [32] and of its association with ERK1/2 activity [37,38,39]. The gene discussed is CDH2; the disease is cancer.